12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·03/04/2026 17:05:40
Listen to the news
Gainers
Firefly Neuroscience (NASDAQ:AIFF) stock increased by 62.3% to $1.11 during Wednesday's regular session. The company's market cap stands at $9.7 million.
Baird Medical Investment (NASDAQ:BDMD) shares moved upwards by 27.6% to $3.18. The market value of their outstanding shares is at $91.4 million.
Can Fite Biopharma (AMEX:CANF) shares rose 26.4% to $6.32. The company's market cap stands at $6.5 million.
Evolus (NASDAQ:EOLS) stock rose 23.69% to $5.11. The market value of their outstanding shares is at $267.7 million. As per the press release, Q4 earnings came out yesterday.
Agilon Health (NYSE:AGL) stock moved upwards by 18.31% to $0.67. The company's market cap stands at $235.1 million.
InMed Pharmaceuticals (NASDAQ:INM) shares increased by 16.81% to $0.89. The market value of their outstanding shares is at $2.2 million.
Losers
SCWorx (NASDAQ:WORX) shares declined by 19.3% to $0.14 during Wednesday's regular session. The market value of their outstanding shares is at $2.8 million.
Adial Pharmaceuticals (NASDAQ:ADIL) shares fell 16.11% to $1.92. The market value of their outstanding shares is at $2.5 million.
Kazia Therapeutics (NASDAQ:KZIA) shares fell 11.04% to $8.9. The market value of their outstanding shares is at $113.4 million.
Rigel Pharmaceuticals (NASDAQ:RIGL) stock declined by 10.15% to $29.67. The company's market cap stands at $592.2 million. The company's, Q4 earnings came out yesterday.
ImmunityBio (NASDAQ:IBRX) stock fell 8.75% to $9.12. The market value of their outstanding shares is at $9.8 billion.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.